Cyclopentane compound
AssigneeKissei Pharmaceutical Co., Ltd.
InventorsAtsushi Kondo, Masako Yoshida, Tsutomu Matsumoto, Akihiro Shiogai, Tomoya Oki
Life of this patent
Estimating the term…
Loading patent…
AssigneeKissei Pharmaceutical Co., Ltd.
InventorsAtsushi Kondo, Masako Yoshida, Tsutomu Matsumoto, Akihiro Shiogai, Tomoya Oki
Estimating the term…
The present invention aims to provide a novel compound which has an OX2R agonist activity. The present invention relates to a cyclopentane compound represented by the following formula (I) or a pharmaceutically acceptable salt thereof. The compound of the present invention or a pharmaceutically acceptable salt thereof has an agonist activity on OX2R and is useful as an agent for the treatment of sleep disorders involving OX2R (for example, narcolepsy, idiopathic hypersomnia, Kleine-Levin syndrome, hypersomnia due to physical diseases, hypersomnia due to psychiatric disorders, hypersomnia due to drugs or substances, circadian rhythm sleep-wake disorder, insufficient sleep syndrome and long sleep) or the like.
A compound represented by the formula (I):
A compound selected from the group consisting of the following compounds:
A compound selected from the group consisting of the following compounds:
Dependencies are inferred from the claim text.